Archives of Pharmacal Research

Archives of Pharmacal Research is published by Pharmaceutical Society of Korea and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Natural product bioactivities and synthesis, Phytochemistry and Biological Activities and Synthesis and biological activity, together about 29.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Archives of Pharmacal Research is the official journal of the Pharmaceutical Society of Korea and has been published since 1976. Archives of Pharmacal Research is an interdisciplinary journal devoted to the publication of original scientific research papers and reviews in the fields of drug discovery, drug development, and drug actions with a view to providing fundamental and novel information on drugs and drug candidates.In the case of research on natural products, the articles reporting the pharmacological effects of the active ingredients in the extracts will be considered for publication. However, studies evaluating the pharmacological actions of only the extracts will not be considered. Manuscripts will be considered for publication on the condition that the results reported are based on original research that has not been published elsewhere in any journal. Upon acceptance for publication of an article in Archives of Pharmacal Research, the author tacitly agrees to make available any materials used in the published experiments, or novel or natural products disclosed in the article that are not commercially available, so that other researchers may confirm the observations. Later on, upon acceptance of your article you will receive an E-mail link to the Author Query and article’s online Proof at Springer’s web page. The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship are not allowed without the approval of the responsible Editor. In such case, please contact the Editorial Office. (E-mail: pskor@korea.com). Corresponding author will automatically receive a free electronic offprint(PDF file) upon issue publication. However, If author wishes to order paper offprints(paid subscription), it is also available by choosing alternative publishing option when through the ‘Author Query/My Publication’ stage at Springer’s web page. This contains info on transfer of copyright, option to order Open Access, paper offprints, posters..etc. Authors should be more careful and be aware that the ‘online proof’ they receive is their final chance to make changes to the article. Editorial office’s policy is that Issuing Erratum after official publication is restrictively allowed and author will be charged for extra Errata handling charge. Subscription rates:For information on subscription rates pleas

From the journal's Aims & Scope

Research area (LetPub): Pharmacology & Pharmacy

Editor-in-chief Seok-Yong LeePublisher website

Editorial board by country: 3 in mainland China (about 3%); most named South Korea 63, United States 11, Japan 5, Mainland China 3, India 2 (96 members with a country) Editorial board ↗Publisher website · 2026-09-29

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEEmbaseCASCurrent ContentsPublisher website

Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

8.2LetPub · 2026-09-13

Impact factor (publisher) 2025

8.2Publisher website · 2026-09-29

5-year impact factor (publisher) 2025

8Publisher website · 2026-09-29

CiteScore 2026-06

13.6LetPub · 2026-09-13

SJR 2026-06

1.84LetPub · 2026-09-13

SNIP 2026-06

1.76LetPub · 2026-09-13

h-index

75LetPub · 2026-09-13

h-index

125OpenAlex · 2026-10-01

i10-index

3,540OpenAlex · 2026-10-01

2-year mean citedness

8.47OpenAlex · 2026-10-01

Self-citation rate

2.4%LetPub · 2026-09-13

Share of gold OA articles

10.43%LetPub · 2026-09-13

Volume

Articles per year

61LetPub · 2026-09-13

Downloads per year (publisher) 2025

569,400Publisher website · 2026-09-29

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

about 4 monthsLetPub · 2026-09-13

Average acceptance (community reports)

50%LetPub · 2026-09-13

Submission to first decision

11 daysPublisher website · 2026-09-29

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

Pharmaceutical Society of Korea

Country or region

SOUTH KOREA

Language

English

Frequency

Monthly

Founded

1978

ISSN

0253-6269

Electronic ISSN

1976-3786

Society / sponsor

Pharmaceutical Society of Korea

Latest issue on the website

Volume 49, Issue 8 (August 2026)

Official links

• Journal homepage ↗LetPub
• Submission system ↗LetPub
• Author guidelines ↗LetPub